Clinical Trial Update: Prevention of Postpartum Hemorrhage in Patients With Severe Preeclampsia Using Carbetocin Versus Misoprostol [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing carbetocin versus misoprostol for prevention of postpartum hemorrhage in patients with severe preeclampsia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage
• Preeclampsia

Drugs mentioned

• Carbetocin (carbetocin)
• MISOPROSTOL (Misoprostol)

Snippet

Sponsor: khalid abd aziz mohamed | Conditions: Severe Pre-eclampsia, Postpartum Condition or Complication | Phase 3 | Status: COMPLETED